Skip to main content
Kothari Fermanatation & Biochem Ltd logo

Kothari Fermanatation & Biochem Ltd — Investor Relations & Filings

Ticker · 507474 ISIN · INE991B01010 BSE.NS Manufacturing
Open in API
Filings indexed 322 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country IN India
Listing BSE.NS 507474

About Kothari Fermanatation & Biochem Ltd

https://www.kothariyeast.in

Kothari Fermentation & Biochem Ltd specializes in the production of yeast and yeast-based derivatives through advanced fermentation technology. The company's primary product portfolio includes compressed yeast, dried yeast, and instant dry yeast, marketed under the brand name Sunrise. These products cater extensively to the bakery and food processing industries. Additionally, the firm operates in the biochemical sector, producing industrial alcohol, extra neutral alcohol, and rectified spirits. Utilizing integrated manufacturing processes, the company focuses on high-quality biochemical solutions for diverse industrial applications, including the beverage and pharmaceutical sectors. Its operations emphasize technical precision in fermentation to ensure product consistency and performance in commercial baking and industrial fermentation processes.

Recent filings

Filing Released Lang Actions
Details are as per the enclosed annexure.
Regulatory Filings Classification · 85% confidence The document is a Board Meeting outcome notice filed under SEBI LODR Regulations 2015 (Reg 30 & 33). It primarily discloses the approval of the audited standalone financial results for the year ended March 31, 2026, along with the auditor’s report and appointment of internal auditors. It is not the full Annual Report (10-K) nor just a scheduling notice (RPA); it is a regulatory compliance announcement of financial results under listing rules. Therefore it falls into the general regulatory announcement category.
2026-05-29 English
Financial Results for the Quarter and Financial Year Ended March 31, 2026
Audit Report / Information Classification · 85% confidence The document is the SEBI Listing disclosure of audited financial results for the quarter and year ended March 31, 2026, including the independent auditor’s report with unmodified opinion and the full Statement of Assets & Liabilities and P&L. This is not a full Annual Report (10-K) or a brief earnings highlight, but a standalone audit report on the financial results, fitting the “Audit Report / Information (AR)” definition. FY 2026
2026-05-29 English
Outcome for Audited (Standalone) Financial Results for the Quarter and Financial Year ended March 31, 2026, Appointment of Internal Auditor
Interim / Quarterly Report Classification · 85% confidence The document is a formal Board Meeting outcome filed under SEBI Listing Regulations 30/33, containing the approved audited financial results (quarterly and full year) together with the auditor’s report and statement of assets/liabilities. It is not merely an announcement that a full report is available (so not RPA), nor is it a standalone annual report (10-K) or an audit report alone (AR). It constitutes a comprehensive periodic financial report for the quarter and year end, matching our definition of an Interim / Quarterly Report (IR). FY 2026
2026-05-29 English
Annual Secretarial Compliance Report for the Financial Year ended on March 31, 2026.
Regulatory Filings Classification · 85% confidence The document is an "Annual Secretarial Compliance Report" prepared and submitted pursuant to SEBI (LODR) Regulations, 2015 (Regulation 24A). It is an attestation by Practicing Company Secretaries confirming statutory compliance and does not contain actual financial statements or serve as an annual/quarterly report. It is a regulatory compliance filing/certificate rather than a full report or financial supplement. Therefore, under the certification rule and the available categories, it should be classified as a general regulatory filing (RNS).
2026-05-29 English
Kothari Fermentation & Biochem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the Audited ....
Regulatory Filings Classification · 91% confidence The document is an intimation/notice under Regulation 29 of SEBI LODR about a Board Meeting date and closure of trading window. It does not include financial statements or results itself, nor does it announce board changes. It is a regulatory compliance notice, fitting the general Regulatory Filings category.
2026-05-21 English
Please refer to the attached annexure.
Regulatory Filings
2026-04-08 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.